{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:51:11Z","timestamp":1792875071570,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ViiV healthcare Positive\u00a0Action","award":["OV212047"],"award-info":[{"award-number":["OV212047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Women who inject drugs (WID) in Nigeria face significant barriers to harm reduction services, including punitive policies, stigma, and gender-based violence, which increase their risk of HIV and hepatitis. This study presents proposed intervention models aimed at enhancing harm reduction services for WID in Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>This study employed a human-centered design approach to develop interventions for WID in Nigeria. The resulting intervention models were informed by qualitative assessments and stakeholder engagement, and were aligned with national health policies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>The key interventions developed include strategic advocacy to engage stakeholders in fostering supportive harm reduction policies, human rights campaigns to address gender-based violence and educate WID on their rights, and training outreach workers in wound management and naloxone administration. Additional measures include the Help Card initiative for reporting GBV and accessing support, the Speak Out intervention, and tailored harm reduction education on safe practices and available resources. A multi-pronged empowerment approach aims to enhance agency, while subsidized healthcare services reduce financial barriers to HBV vaccination and cervical cancer screening. Social protection initiatives integrate WID into safety nets, ensuring access to health insurance, child advocacy, and nutritional support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The package of interventions offers a promising, multi-dimensional approach to harm reduction for WID in Nigeria. Through human-centered design and stakeholder engagement, the interventions address both structural and individual barriers, creating scalable and sustainable strategies adaptable to regional\u00a0contexts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13690-025-01753-7","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:48:06Z","timestamp":1763005686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Package of interventions for harm reduction among women who inject drugs in Nigeria"],"prefix":"10.1186","volume":"83","author":[{"given":"Aisha Nantim","family":"Dadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olujide Olusesan","family":"Arije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kene","family":"Eruchalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Anyanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omokhudu","family":"Idogho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamen","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peace","family":"Ikani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"3","key":"1753_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10461-013-0540-y","volume":"18","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W, Lampkin H, Shannon K, Kerr T. People knew they could come here to get help\u201d: an ethnographic study of assisted injection practices at a peer-run \u2018unsanctioned\u2019supervised drug consumption room in a Canadian setting. AIDS Behav. 2014;18(3):473\u201385.","journal-title":"AIDS Behav"},{"issue":"1","key":"1753_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/10826084.2021.1990339","volume":"57","author":"EUE Nelson","year":"2022","unstructured":"Nelson EUE. Rationalities of space and drug-related harms: accounts of people who inject drugs in Nigeria. Subst Use Misuse. 2022;57(1):114\u201322.","journal-title":"Subst Use Misuse"},{"issue":"Suppl 1","key":"1753_CR3","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1097\/QAI.0000000000002424","volume":"85","author":"J Iversen","year":"2020","unstructured":"Iversen J, Page K, Madden A, Maher L. HIV, HCV and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr. 2020;85(Suppl 1):S97\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000002424.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1753_CR4","unstructured":"UNODC. World Drug Report 2018: Booklet 5 - Women and Drugs. Drug use, drug supply and their consequences. United Nations Office on Drugs and Crime; 2018. (United Nations Publications, Sales No. E.18.XI.9). https:\/\/www.unodc.org\/wdr2018\/prelaunch\/WDR18_Booklet_5_WOMEN.pdf"},{"key":"1753_CR5","unstructured":"UNAIDS, UNODC. Addressing the specific needs of women who inject drugs: Practical guide for service providers on gender-responsive HIV services 2016. https:\/\/www.unodc.org\/documents\/hiv-aids\/2016\/Addressing_the_specific_needs_of_women_who_inject_drugs_Practical_guide_for_service_providers_on_gender-responsive_HIV_services.pdf"},{"key":"1753_CR6","unstructured":"World Medical Association. Declaration of Helsinki: World Medical Association; 2004. Available: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects"},{"key":"1753_CR7","doi-asserted-by":"crossref","unstructured":"Okonkwo P, Olatoregun OJ, Abolarin O, Olajide O, Olatoregun O. Barriers to accessing antiretroviral treatment among key populations in Southwest Nigeria. Cureus 2024;16(4):1-12.","DOI":"10.7759\/cureus.59312"},{"key":"1753_CR8","unstructured":"World Health Organization. Women who inject drugs and HIV: Addressing specific needs. World Health Organization 2012. https:\/\/cdn.who.int\/media\/docs\/default-source\/substance-use\/policy-brief-women-inject-drugs.pdf"},{"key":"1753_CR9","unstructured":"WACD. Not just in transit: Drugs, the state and society in West Africa. West Africa Commission on Drugs 2014. https:\/\/www.unodc.org\/documents\/ungass2016\/Contributions\/IO\/WACD_report_June_2014_english.pdf"},{"key":"1753_CR10","doi-asserted-by":"publisher","DOI":"10.25259\/IJMA_49_2024","author":"GO Emmanuel","year":"2025","unstructured":"Emmanuel GO, Sanni OF, Roger A, Umoh P, Boniface OB, Paul A, et al. Improving HIV prevention for key populations in Nigeria: insights on access, barriers, stigma, and service utilization. Int J Matern Child Health AIDS. 2025. https:\/\/doi.org\/10.25259\/IJMA_49_2024.","journal-title":"Int J Matern Child Health AIDS"},{"key":"1753_CR11","doi-asserted-by":"crossref","unstructured":"Nelson EU, Akpabio G, Essien N, Obot I. Drug problems and treatment services at the community level: findings from a national sample of key informants in Nigeria.\u00a0J Subst Use 2024;1\u20137","DOI":"10.1080\/14659891.2024.2403076"},{"issue":"1","key":"1753_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4314\/ahs.v21i1.17","volume":"21","author":"C Eze","year":"2021","unstructured":"Eze C, et al. Strategies for improving healthcare access for vulnerable groups in Nigeria. Afr Health Sci. 2021;21(1):123\u201336.","journal-title":"Afr Health Sci"},{"issue":"4","key":"1753_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/09687637.2019.1684446","volume":"27","author":"EUE Nelson","year":"2020","unstructured":"Nelson EUE, Brown AS. Extra-legal policing strategies and HIV risk environment: accounts of people who inject drugs in Nigeria. Drugs Educ Prev Policy. 2020;27(4):312\u20139.","journal-title":"Drugs Educ Prev Policy"},{"key":"1753_CR14","doi-asserted-by":"publisher","unstructured":"Bakare S. Key Population, HIV and human rights in Nigeria: Country context analysis. SSRN Electronic Journal. 2023 https:\/\/doi.org\/10.2139\/ssrn.4256264","DOI":"10.2139\/ssrn.4256264"},{"issue":"2","key":"1753_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/ijsw.12045","volume":"23","author":"M Salter","year":"2014","unstructured":"Salter M, Breckenridge J. Women, trauma and substance abuse: understanding the experiences of female survivors of childhood abuse in alcohol and drug treatment. Int J Soc Welfare. 2014;23(2):165\u201373.","journal-title":"Int J Soc Welfare"},{"key":"1753_CR16","unstructured":"Argento EM. Exploring trajectories of drug use, violence, and suicidality among marginalized women: Avenues of intervention and the therapeutic potential of psychedelics [Doctoral dissertation, University of British Columbia].2019; University of British Columbia Library Open Collections. http:\/\/hdl.handle.net\/2429\/70676"},{"key":"1753_CR17","unstructured":"Milliken S. \"Here, I feel completely whole\": Exploring how YWCA Hamilton's Safer Drug Use Space supports women and non-binary people experiencing gender-based homelessness [master's thesis]. McMaster University;\u00a02023. https:\/\/macsphere.mcmaster.ca\/bitstream\/11375\/28906\/2\/milliken_stephanie_finalsubmission2023september_MSW.pdf"},{"key":"1753_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0214-1","volume":"15","author":"CM Stengel","year":"2018","unstructured":"Stengel CM, Mane F, Guise A, Pouye M, Sigrist M, Rhodes T. They accept me, because I was one of them\u201d: formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal. Harm Reduct J. 2018;15:1\u201312.","journal-title":"Harm Reduct J"},{"key":"1753_CR19","unstructured":"Sullivan G. A gendered analysis of implementation and impacts of prescribed safer supply in BC: a qualitative exploration during dual public health emergencies [Doctoral dissertation]. University of Victoria; 2023. https:\/\/dspace.library.uvic.ca\/server\/api\/core\/bitstreams\/b099e229-637c-4aa2-b479-13099a72662a\/content"},{"issue":"12","key":"1753_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9120287","volume":"9","author":"E Villacis-Alvarez","year":"2024","unstructured":"Villacis-Alvarez E, Sobie C, Maier K, Lavallee M, Daniels C, Pashe H, et al. Gender and intersecting barriers and facilitators to access the HIV cascade of care in Manitoba, Canada, before and during the COVID-19 pandemic: a qualitative study. Trop Med Infect Dis. 2024;9(12):287.","journal-title":"Trop Med Infect Dis"},{"key":"1753_CR21","doi-asserted-by":"crossref","unstructured":"Schwartz S, Viswasam N, Abdalla P. Integrated interventions to address sex workers\u2019 needs and realities: academic and community insights on incorporating structural, behavioural, and biomedical approaches.\u00a0Sex Work Health Hum Rights\u00a02021;231-53.","DOI":"10.1007\/978-3-030-64171-9_13"},{"key":"1753_CR22","volume-title":"Ergonomics of human\u2013system interaction\u2014Part 210: Human-centred design for interactive systems (ISO 9241\u2013210:2019)","author":"International Organization for Standardization","year":"2019","unstructured":"International Organization for Standardization. Ergonomics of human\u2013system interaction\u2014Part 210: Human-centred design for interactive systems (ISO 9241\u2013210:2019). Geneva: ISO; 2019."},{"key":"1753_CR23","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.drugpo.2005.02.009","volume":"16","author":"R Needle","year":"2005","unstructured":"Needle R, Burrows D, Friedman SR, Dorabjee J, Touz\u00e9 G. Effectiveness of community-based outreach in preventing HIV\/AIDS among injecting drug users. Int J Drug Policy. 2005;16:S45-57.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1753_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.socscimed.2004.12.024","volume":"61","author":"T Rhodes","year":"2005","unstructured":"Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1025\u201344.","journal-title":"Soc Sci Med"},{"issue":"2","key":"1753_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11904-010-0043-7","volume":"7","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV AIDS Rep. 2010;7(2):99\u2013106.","journal-title":"Curr HIV AIDS Rep"},{"issue":"1","key":"1753_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540120500101625","volume":"18","author":"SG Sherman","year":"2006","unstructured":"Sherman SG, German D, Cheng Y, Marks M, Bailey-Kloche M. The evaluation of the JEWEL project: an innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS Care. 2006;18(1):1\u201311.","journal-title":"AIDS Care"},{"issue":"1","key":"1753_CR27","first-page":"20","volume":"119","author":"KM Blankenship","year":"2004","unstructured":"Blankenship KM, Bray SJ. The role of structural factors in the spread of HIV among drug users. Public Health Rep. 2004;119(1):20\u201336.","journal-title":"Public Health Rep"},{"issue":"3","key":"1753_CR28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0b013e3181cdaba0","volume":"54","author":"DM Tuller","year":"2010","unstructured":"Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Food insecurity and morbidity among HIV-infected individuals receiving antiretroviral therapy in Uganda: a cross-sectional analysis. J Acq Immune Defic Syndr (1999). 2010;54(3):304.","journal-title":"J Acq Immune Defic Syndr (1999)"},{"key":"1753_CR29","unstructured":"UNAIDS. 2020 Global AIDS update\u2014seizing the moment\u2014tackling entrenched inequalities to end epidemics, 2020. https:\/\/www.unaids.org\/en\/resources\/documents\/2020\/global-aids-report"},{"key":"1753_CR30","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations \u2013 2016 update. World Health Organization; 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241511124"},{"issue":"2","key":"1753_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2006.11.006","volume":"18","author":"SR Friedman","year":"2007","unstructured":"Friedman SR, de Jong W, Rossi D, Touz\u00e9 G, Rockwell R, Des Jarlais DC, et al. Harm reduction theory: users\u2019 culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users\u2019 groups. Int J Drug Policy. 2007;18(2):107\u201317.","journal-title":"Int J Drug Policy"},{"key":"1753_CR32","unstructured":"UNAIDS. Financing the HIV response. UNAIDS 2018."},{"key":"1753_CR33","unstructured":"World Health Organization. Making fair choices on the path to universal health coverage: Final report of the WHO Consultative Group on Equity and Universal Health Coverage. World Health Organization; 2014. https:\/\/www.who.int\/publications\/i\/item\/9789241507158"},{"issue":"23","key":"1753_CR34","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1056\/NEJMra1201533","volume":"368","author":"P Piot","year":"2013","unstructured":"Piot P, Quinn TC. Response to the AIDS pandemic\u2014a global health model. N Engl J Med. 2013;368(23):2210\u20138.","journal-title":"N Engl J Med"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-025-01753-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:57:37Z","timestamp":1781614657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13690-025-01753-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1186\/s13690-025-01753-7","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the institutional review board of the National Institute of Medical Research with the registration number IRB\/23\/049. Written informed consent was obtained from all participants, ensuring compliance with ethical standards for research involving human subjects. The study adhered to the principles of confidentiality, anonymity, and voluntariness throughout the data collection and analysis phases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}